Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00769392 · ClinicalTrials.gov registry record · NA
Pilot Study: A Randomized Trial Of Anesthetic Agents For Intravitreal Injection
A NA study of Macular Degeneration, sponsored by Lahey Clinic.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 3
- Study locations
NCT00769392 is a NA study of Macular Degeneration that has completed, run by Lahey Clinic. The registered enrollment target is 28 participants, below the 178-participant average among 26 other Macular Degeneration trials with a reported enrollment target (84% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT00769392, a NA study of Macular Degeneration, has completed, sponsored by Lahey Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study is designed to compare four currently used types of anesthesia used prior to intravitreal injection in order to evaluate the most effective method of anesthesia in reducing pain and discomfort associated with intravitreal injections.
Conditions Studied
Interventions
- DRUG Proparacaine Ophthalmic
- DRUG Tetracaine Ophthalmic
- DRUG Lidocaine 4%
- DRUG Lidocaine 2% Injectable Solution
Study Locations (3)
Massachusetts
- Lahey Clinic Arlington - Arlington
- Lahey Clinic, Inc. - Burlington
- Lahey Clinic Northshore - Peabody
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2008-09 |
| Est. Completion | 2009-08-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00769392
The ClinicalTrials.gov registry entry for NCT00769392 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 178-participant average among 26 other Macular Degeneration trials with a reported enrollment target (84% lower). The listed sponsor is Lahey Clinic, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Macular Degeneration appearing as the primary indexed condition, and to 4 interventions - of which Proparacaine Ophthalmic is the first listed.
NCT00769392 reports 3 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00769392 about?
NCT00769392 is a clinical study titled "Pilot Study: A Randomized Trial Of Anesthetic Agents For Intravitreal Injection". This study is designed to compare four currently used types of anesthesia used prior to intravitreal injection in order to evaluate the most effective method of anesthesia in reducing pain and discomfort associated with intravitreal injections.
What is the current status of trial NCT00769392?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2008-09. Estimated completion is 2009-08-12.
What conditions does trial NCT00769392 study?
This clinical trial studies the following conditions: Macular Degeneration.
What interventions are being tested in trial NCT00769392?
The interventions under investigation include: Proparacaine Ophthalmic (DRUG), Tetracaine Ophthalmic (DRUG), Lidocaine 4% (DRUG), Lidocaine 2% Injectable Solution (DRUG).
Who is sponsoring clinical trial NCT00769392?
This trial is sponsored by Lahey Clinic, which has 43 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00769392 being conducted?
This trial has 3 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Macular Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Factors in Learning And Plasticity: Macular Degeneration
RECRUITING · NA
-
Factors in Learning And Plasticity: Healthy Vision
ACTIVE NOT RECRUITING · NA
-
Evaluation of a New Eye-specific Multivitamin Formula in Participants at Risk of Age-related Macular Degeneration (AMD)
COMPLETED · NA
-
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RECRUITING · Phase 2
-
Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
RECRUITING · Early Phase 1
-
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.